United States: Will Exclusionary Criteria Be Excluded As Claim Limitations? Time Will Tell As PTAB Institutes IPR In Mylan v. Regeneron - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

United States: Will Exclusionary Criteria Be Excluded As Claim Limitations? Time Will Tell As PTAB Institutes IPR In Mylan v. Regeneron - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

Published

In the institution decision for Mylan Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc., IPR2022-01225, Paper 21 (P.T.A.B. Jan. 11, 2023), the Patent Trials & Appeals Board ("the Board")...

Full Article